2H-3,9a-Methano-1-benzoxepin-2-carbonitrile,octahydro-5a-methyl-8-oxo-2-phenyl- (106112-04-3)

Identification
Name:	2H-3,9a-Methano-1-benzoxepin-2-carbonitrile,octahydro-5a-methyl-8-oxo-2-phenyl-
CAS:	106112-04-3
Molecular Formula:	C₁₉H₂₁NO₂
Molecular Structure:
Properties
Safety Data

Other Product

3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2Z)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-4-oxo-2H-3,9a-methano-1-benzoxepin-6-ylester
3-Furancarboxylic acid,5a-[(acetyloxy)methyl]octahydro-9,10-dihydroxy-2,2,9-trimethyl-6,7-bis(2-methyl-1-oxobutoxy)-2H-3,9a-methano-1-benzoxepin-5-ylester (9CI)
3-Furancarboxylic acid,5a-[(acetyloxy)methyl]octahydro-9,10-dihydroxy-2,2,9-trimethyl-7-(2-methyl-1-oxobutoxy)-2H-3,9a-methano-1-benzoxepin-5,6-diylester (9CI)
3-Furancarboxylic acid,10-(acetyloxy)-5a-[(acetyloxy)methyl]octahydro-9-hydroxy-2,2,9-trimethyl-6,7-bis(2-methyl-1-oxobutoxy)-2H-3,9a-methano-1-benzoxepin-5-ylester (9CI)
Butanoic acid,2-methyl-,6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[(1-oxo-3-phenyl-2-propenyl)oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
2-Propenoic acid,3-phenyl-,(3S,4S,5S,5aS,6R,7S,9S,9aS,10R)-4,7-bis(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9,10-dihydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-ylester
2-Propenoic acid,3-phenyl-,(3R,4S,5S,5aR,6R,7S,9S,9aS,10R)-7-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-4,9,10-trihydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-ylester (9CI)
2-Propenoic acid,3-phenyl-,6,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4-ylester, (3R,4R,5S,5aS,6S,9S,9aS,10R)- (9CI)
2-Propenoic acid,3-phenyl-,(3R,4R,5S,5aS,6S,9S,9aS,10R)-4,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-ylester
Butanoic acid,2-methyl-,10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6,7-diylester (9CI)
Spiro[3H-benz[e]indene-3,9'-[9H-3,9a]methano- [1]benzoxepin]-2',8(2H,3'H)-dione,4,5',6',7'- tetrakis(acetyloxy)-1,3a,4,4',5,5',5a,5'a,6',7',8',9,- 9a,9b-tetradecahydro-8'-hydroxy-7-methoxy- 2,3',5a,5'a,6,8',9b-heptamethyl-,(2S,3S,3'R,- 3aS,4R,5'S,5aS,5'aR,6'R,7'R,8'R,9aS,9bS,9'aR)-
octahydro-3,6,6-trimethyl-2H-3,9a-methano-1-benzoxepin-2-one
2-Propenoic acid,3-phenyl-,esters,(3R,5S,- 5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-2,2,- 5a,9-tetramethyl-2H-3,9a-methano-1- benzoxepin-5,7-diyl ester,(2E,2'E)-
3-Furancarboxylic acid,3,3'-[(3R,4R,5R,5aS,6R,7S,9S,9aS,10R)-6,7,10-tris(acetyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-5a-[(2-methyl-1-oxopropoxy)methyl]-2H-3,9a-methano-1-benzoxepin-4,5-diyl]ester
3-Pyridinecarboxylicacid,(3R,5S,5aR,6R,7S,9R,9aS,10R)-7,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-6-[(2S)-2-methyl-1-oxobutoxy]-2H-3,9a-methano-1-benzoxepin-5-ylester
3-Pyridinecarboxylic acid,esters,[6,7-bis(acetyloxy)-5-(benzoyloxy)- octahydro-4-hydroxy-2,2,9-trimethyl-5aH-3,- 9a-methano-1-benzoxepin-5a-yl]methyl ester,(3R,4S,5S,5aS,6S,7R,9S,9aR)-rel-
3-Pyridinecarboxylicacid,(3R,5S,5aS,6S,9R,9aS,10R)-6,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-5-ylester (9CI)
3-Pyridinecarboxylicacid,(3S,4S,5S,5aS,6S,9R,9aS)-5-(acetyloxy)-5a-[(acetyloxy)methyl]-6-(benzoyloxy)octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4-ylester (9CI)